Biscayne Neurotherapeutics completes venture financing

Neurology company Biscayne Neurotherapeutics Inc. (Miami, Fla.) raised $3 million in a series B round co-led by Quark Venture's Global Health Sciences Fund, GF Securities and Mesa Verde Venture Partn...